Monarch Partners Asset Management LLC - BIOSPECIFICS TECHNOLOGIES CO ownership

BIOSPECIFICS TECHNOLOGIES CO's ticker is BSTC and the CUSIP is 090931106. A total of 1 filers reported holding BIOSPECIFICS TECHNOLOGIES CO in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Monarch Partners Asset Management LLC ownership history of BIOSPECIFICS TECHNOLOGIES CO
ValueSharesWeighting
Q3 2020$1,360,000
+56.3%
25,751
+81.3%
0.31%
+44.3%
Q2 2020$870,000
+8.3%
14,2010.0%0.21%
-24.8%
Q1 2020$803,000
+23.9%
14,201
+24.7%
0.28%
+95.8%
Q4 2019$648,000
+41.8%
11,386
+33.4%
0.14%
+108.7%
Q3 2019$457,000
+1.8%
8,536
+13.4%
0.07%
+7.8%
Q2 2019$449,000
+14.5%
7,526
+19.5%
0.06%
+8.5%
Q1 2019$392,000
-30.1%
6,296
-32.0%
0.06%
-27.2%
Q4 2018$561,0009,2560.08%
Other shareholders
BIOSPECIFICS TECHNOLOGIES CO shareholders Q4 2020
NameSharesValueWeighting ↓
JW Asset Management, LLC 73,649$3,646,0002.32%
Stonepine Capital Management, LLC 59,878$2,965,0001.60%
NORTHPOINTE CAPITAL LLC 109,644$5,428,0000.57%
Elk Creek Partners, LLC 145,406$7,199,0000.47%
TFS CAPITAL LLC 18,208$901,0000.35%
RICE HALL JAMES & ASSOCIATES, LLC 161,671$8,004,0000.35%
Ativo Capital Management LLC 19,592$970,0000.26%
Matarin Capital Management, LLC 57,034$2,823,753,0000.26%
ISTHMUS PARTNERS, LLC 16,505$817,0000.24%
Stanley-Laman Group, Ltd. 12,546$621,0000.17%
View complete list of BIOSPECIFICS TECHNOLOGIES CO shareholders